Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · U.S. Physical Therapy (USPH)

U.S. Physical Therapy Q3 revenue rose 17.8%; net income reached $13.1 million, guidance reaffirmed

Positive Impact 3 of 5 earnings Written later

U.S. Physical Therapy reported third-quarter 2025 results, with physical therapy revenue up 17.8% to $168.1 million and net income attributable to shareholders rising to $13.1 million, or $0.48 per share, from $6.6 million, or $0.39 per share, a year earlier. Management reaffirmed its full-year 2025 Adjusted EBITDA guidance of $93.0 million to $97.0 million and declared a $0.45 quarterly dividend.

Key points

  • Physical therapy revenue rose 17.8% to $168.1 million; patient visits rose 18.0% to 1,554,207.
  • Net income attributable to USPH shareholders was $13.1 million ($0.48 per share) vs. $6.6 million ($0.39 per share) a year earlier.
  • Operating Results, a non-GAAP measure, fell to $10.1 million ($0.66 per share) from $10.4 million ($0.69 per share).
  • Full-year 2025 Adjusted EBITDA guidance of $93.0 million to $97.0 million was reaffirmed; $0.45 dividend payable December 12, 2025 to holders of record November 17, 2025.

The filing

CompanyU.S. Physical Therapy (USPH)
Form8-K, current report
Filed with the SECNov 6, 2025, 4:22 PM ET
Accession number0000885978-25-000053

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.